DRIO - Company ID 0001533998
The table below shows DarioHealth Corp.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $22.36M | $27.04M | $20.35M | $27.66M | $20.51M | $7.58M |
| Cost of revenue | $9.69M | $13.77M | $14.37M | $18.00M | $16.55M | $5.06M |
| Gross profit | $12.66M | $13.27M | $5.98M | $9.65M | $3.96M | $2.51M |
| R&D | $13.79M | $24.18M | $20.25M | $19.65M | $17.22M | $4.43M |
DarioHealth Corp. reported annual revenue of $22.36M for fiscal year 2025. That is down 17.3% from $27.04M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.80M (FY 2016) to $22.36M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $15.19M |
| $20.48M |
| $18.14M |
| $16.49M |
| $23.53M |
| $12.76M |
| Operating income | -$36.66M | -$57.74M | -$56.19M | -$56.81M | -$76.49M | -$29.90M |
| Income tax | $105.00K | -$1.85M | $64.00K | $4.00K | $32.00K | - |
| Net income | -$41.71M | -$42.75M | -$59.43M | -$62.19M | -$76.76M | -$29.45M |
| EPS (diluted) | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 | $4.01 |